Lab findings suggest EGFR inhibitors may prevent rhabdomyosarcoma recurrenceRhabdomyosarcoma is a type of soft tissue cancer. Scientists at St. Jude Children's Research Hospital studied the population of cells that persists after therapy, causing rhabdomyosarcoma recurrence.